Not to go over the same points, but I certainly questioned the raise/ purchase of Reckon at the time. Without question, it has turned out to be an inspired piece of business by PC for all the reasons already outlined. When questioning the implementation, please watch Peter's last quarterly update, as he clearly states that the integration to Reckon One has been completed and revenues have already started to flow.
Re the speculation relating to the Reckon price post the distribution of the special dividend. Let's not forgot that we are currently in a risk off environment were valuations have been hammered and when the market turns Reckon will appreciate in value based on its SaaS model which is income generating, strong balance sheet and experienced management team. This is the definition of a win win investment for Novatti - any revenues derived through the partnership are shared equally and should translate into higher valuations for both entities over time.
- Forums
- ASX - By Stock
- Novatti - The $1 party
Not to go over the same points, but I certainly questioned the...
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.81M |
Open | High | Low | Value | Volume |
3.7¢ | 4.1¢ | 3.4¢ | $187.9K | 4.949M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 127555 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27555 | 0.034 |
4 | 217935 | 0.033 |
8 | 525120 | 0.032 |
8 | 506731 | 0.031 |
10 | 1286467 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 150000 | 1 |
0.036 | 1300000 | 1 |
0.038 | 100000 | 1 |
0.039 | 400000 | 2 |
0.040 | 2342775 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online